Early this year, VitaDAO announced a $4.1 million fundraising round, that included strategic members and longevity enthusiasts such as Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Balaji Srinivasan, and Joe Betts-LaCroix.

In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging.

Following our successful fundraise of $4.1 million (check out the Forbes article), a new wave of projects are in the pipeline to be funded. First up in 2023 is Brain Tissue Replacement Therapy with Jean Hebert

The Longevity field is starting the year strongly with new updated Hallmarks of aging, exactly 10 years after the original paper was published. So time to update your introduction slides with the figure we will see in every presentation for the next

2023 kicks off with strong support for longevity research and a huge step for decentralized science(DeSci)

What a year it has been! 2022 was a year full of growth, science, and a whole lot of funded longevity research. In the 1.5 years since VitaDAO’s historic Genesis auction, VitaDAO has funded 15+ longevity projects and gathered 9000+ community members

As the end of the year is fast approaching we wanted to look back and appreciate all the effort and hard work of the researchers in the VitaDAO community - from students, postdocs and fellows to principal investigators

Therapies that act synergistically are needed to significantly promote longevity

A multitude of discoveries and inventions throughout history have been made by people who were initially trained in one domain, but were able to make a significant contribution to a different field due to their ability to look at a problem with a uni

Inside: A Recap of VitaDAO’s 2nd “Crypto meets Longevity Symposium” VitaDAO Fellowship Update New VitaSpotlight Series: Rapamycin as a Promising Aging Intervention How to contribute to VitaDAO and ResearchHub’s Community Driven Paper Meet DAO Membe

It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute reject

Some species in the animal kingdom live extraordinarily long lives. They seem to be somehow protected from all the damage that we would expect to accumulate in aged tissues. Many are very large, like bowhead whales, and there is an established correl

Happy DeSci Fall! Inside this month’s newsletter: VitaDAO’s 5th IP-NFT Funding Ceremony A New Publication on Decentralized Technology Transfer The Longevity Decentralized Review Explainer Meet DAO Member: Estèfano Pinilla

The transfer of technology (TT) is essential in turning intellectual property (IP) generated from innovative research into real-world applications that benefit the general public.

Welcome back to our monthly newsletter! This month we are excited to bring you an interview with Dr. Marco Demaria who has made some significant contributions to our understanding of cellular senescence. 

Dear Vitalians, We are glad you are here! Inside this month’s newsletter: Pfizer, L1 Digital and Shine Capital Contribution Proposals Passed VitaDAO Proposals Meet DAO Member: Hamza Qureshi Upcoming Events, including a 2nd VitaDAO Crypto meets Long

Set up MetaMask and receive your first VITA tokens

We can all agree that the age-associated decline in physiological functionality and increased risk of developing diseases is terrible, but what can we do to treat, slow down or even prevent it?

Dear Vitalians, happy DeSci-Summer! Inside this month’s newsletter: Longevity Prize in collaboration with Foresight and Methuselah Foundation Multichain Voting VitaDAO’s Fourth IP-NFT Ceremony Upcoming Events

We are announcing The Longevity Prize in collaboration with Foresight.‍ A series of prizes to honor and accelerate progress in longevity and rejuvenation. ‍The longevity prize encourages novel approaches for turning back our aging clocks.

Why do we age? Is aging a result of a genetic program encoded within each of our cells, or is it simply a consequence of damage accumulation throughout life?

June was a month of celebration for VitaDAO! This June, VitaDAO celebrated its first birthday, held a ceremony for the transfer of VitaDAO's third IP-NFT, and completed another Gitcoin Grant Round.

Welcome back to VitaDAO’s monthly longevity research newsletter — we hope you enjoyed our maiden issue!

老化克服や寿命延長を目的とした医薬品開発を自律分散型組織(decentralized autonomous organization, DAO)によって主導するVitaDAOについて日本の読者の方々にご紹介します。Wikipediaによれば、DAO とは、「中央集権的なリーダーシップが介在しないメンバー保有のコミュニティであり、DAOの金融取引記録やプログラムルールがブロックチェーンによって管理されている」と定義されています。

They say April showers bring May flowers. Instead of flowers, we hope we rose to the occasion with June’s newsletter to show how VitaDAO flourished this May.

Welcome Vitalians to the inaugural issue of VitaDAO’s Monthly Longevity Research Newsletter!

Hello Vitalians! April Fools might have started the month, but we promise this Newsletter is no joke! Many people in VitaDAO were able to attend ETHAmsterdam for one of the first ever DeSci days, featuring talks about all things DeSci

By focusing anywhere but the US, DeSci can solve the hardest problems with science & medicine.

Hello Vitalians! Another month, another newsletter- and we couldn’t be more excited about it. Many of the core contributors to the DAO were able to meet up in sunny ☀️ Lisbon this month to organize, bond, and brainstorm in person.

PrimeDAO is building tools that turn DeFi into a cooperative ecosystem.

Humans can instinctively recognize if someone appears older or younger than their age; so then, it should be apparent that many species, including humans, develop age-related changes at different rates.

We know we say it every month, but the VitaDAO community has been busy. We’ve been told to shorten these newsletters, but in all honesty, all that happened in VitaDAO this month makes that difficult!

Save gas fees by using Gnosis Chain (formerly xDai Chain) — DISCLAIMER: This guide is intended only for people who want to get VITA for use in VitaDAO. Part 1: Get started...

If you have been following the longevity field for even just a little a while, you have probably heard of NAD+… a lot. So what is NAD+, and why are people excited about it?

The current drug development system reflects an incentive structure that is anti-competitive and neglects the potential to repurpose existing therapies.

In this January edition of the VitaDAO Newsletter, you can learn about VitaDAO proposals that passed over the last month, get to know DAO rockstar Alex Dobrin, and more!

The VitaDAO community has been hard at work this year pioneering the future of longevity research and IP-NFTs. These past few weeks have been particularly exciting! In this December edition of the VitaDAO Newsletter you will find updates on what has

Under the current system, patent protection is critical for developing a new therapy.

Originally described as gradual deterioration over time, senescence has taken on a much more intricate meaning in the past few decades.

We are getting quite good at extending lifespan, or at least we are getting quite good at extending the lifespan of laboratory animals as complex as mice.

This article will guide you through the process of using Uniswap to obtain VITA, VitaDAO’s token. For more information on VitaDAO itself, see this blog post as well as further links at the bottom of this article.

We’re excited to introduce the opening project to be funded by VitaDAO — the world’s first decentralized intellectual property collective.

Hello world! Hello VitaDAO